JosephPaulCotropiaMD

Physician

Dr. Cotropia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
800 Raymond Stotzer Parkway
Building 1904 Office 2106
College Station, TX 77845
Phone+1 469-512-8917

Fax+1 305-832-0519

University of Texas at Austin Dell Medical SchoolResidency, Internal Medicine, 1981 - 1983
Texas Health Resources (Dallas)Residency, Internal Medicine, 1979 - 1980
University of Texas Southwestern Medical SchoolClass of 1973

PubMed

35 citations
Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vacc...
Flavia Ferrantelli, Moiz Kitabwalla, Robert A. Rasmussen, Chuanhai Cao, Ting-Chao Chou
The Journal of Infectious Diseases. 2004-01-01
35 citations
A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates.
Joseph Cotropia, Kenneth E. Ugen, Srisakul Kliks, Kristina Broliden, P A Broliden
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1996-07-01
13 citations
Antigen expression and cell surface properties of human leukemic blasts.
J. P. Cotropia, Jordan U. Gutterman, Evan M. Hersh, C. H. Granatek, Giora M. Mavligit
Annals of the New York Academy of Sciences. 1976-09-01

Blue Skies; Enzolytics Inc (OTCMKTS: ENZC) BioClonetics MergerNovember 28th, 2020
$0.0217 Price to Beat: Enzolytics Inc (OTCMKTS: ENZC); BioClonetics MergerNovember 1st, 2020
Enzolytics, Inc. Shares BioClonetics Immunotherapeutics, Inc. Company UpdateOctober 19th, 2020
Join now to see all